
- ONCOLOGY Vol 14 No 10
- Volume 14
- Issue 10
Settling on an Increased NCI Budget
The final numbers are not in yet, but there is no doubt that Congress will fund the National Cancer Institute (NCI) at a considerably higher level than the $3.505 billion the Clinton administration asked for. That fiscal 2001 request was already nearly 6% above the actual 2000 budget.
The final numbers are not in yet, but there is no doubt that Congress will fund the National Cancer Institute (NCI) at a considerably higher level than the $3.505 billion the Clinton administration asked for. That fiscal 2001 request was already nearly 6% above the actual 2000 budget. The House approved $3.793 billion and the Senate went one betterto $3.804 billion. At the end of July, a House and Senate conference committee agreed to a compromise budget number for all the NIH institutes. Those numbers were not available at press time but were planned for release by October. It is safe to assume that the NCI budget will be somewhere between the House and Senate number. The size of the increase, of course, is good news. But the House and Senate enumerated a number of specific cancer research areas they expected to get more attention.Those earmarks can sometimes cause problems between cancer advocacy groups. The House, for example, lists 18 separate areas it expects the NCI to get a move on, including esophageal and stomach cancers, endometrial and cervical cancers, lung cancer screening, and urologic cancers.
Articles in this issue
about 25 years ago
New Awards Spotlight Courage of Cancer Survivorsabout 25 years ago
Children’s Art Project at M. D. Anderson Cancer Centerabout 25 years ago
Computer Billing Standardabout 25 years ago
Ligand Receives FDA Marketing Clearance for Bexarotene Gelabout 25 years ago
Mayo Clinic Study Shows Patients Uncertain About Cancer Risk Termsabout 25 years ago
Multidisciplinary Management of Pediatric Soft-Tissue Sarcomaabout 25 years ago
Follow-up Care for Cancer: Making the Benefits Equal the CostNewsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.